BioCentury
ARTICLE | Clinical News

ALZ-801: Additional Phase III data

November 16, 2015 8:00 AM UTC

Pooled data from a subgroup of 252 mild to moderate AD patients homozygous for apolipoprotein E epsilon 4 ( APOE4) in a North American Phase III trial and a European Phase III trial showed that twice...